-
Document de presse | 2022.07.13
Light shed on SARS-CoV-2 replication in bat cells
Bats are reservoir species for numerous viruses including coronaviruses. Given that they do not appear to be affected by diseases transmitted by these viruses, there is potential benefit in understanding how their immune system regulates infection. Scientists at the Institut Pasteur and the CNRS studied SARS-CoV-2 replication in bat cells, which involved using real-time imaging techniques for the...
-
Document de presse | 2023.01.25
Discovery of a circovirus involved in human hepatitis
Scientists from the Institut Pasteur, Necker-Enfants Malades Hospital (AP-HP), Inserm in the Imagine Institute, Université Paris Cité and the Alfort National Veterinary School (EnvA) have identified a previously unknown species of circovirus, provisionally named human circovirus 1 (HCirV-1). Circoviruses are a family of small, highly resistant DNA viruses that were initially identified in 1974 in...
-
Article | 2023.04.04
4-year Research Group - Call for nomination at the Hellenic Pasteur Institute
A 4-year Group leaders’ position is open at the Hellenic Pasteur Institute on one (1) of the following topics.
-
Portrait | 2023.10.02
Javier Pizarro-Cerda : science, plague and rock'n roll!
Javier Pizarro-Cerda's upbringing gave him curiosity, an interest in biology and science, as well as a lifelong passion for music! After his studies in Costa Rica, he came to Europe to become a scientist.Today at the Institut Pasteur in Paris, his research on plague and other Yersinia infections follows on from the work of his predecessors and also explores the history of deadly epidemics of the...
-
News | 2023.12.18
Climate and health: the latest on a silent epidemic
While the main outcome of COP28 was an agreement calling on the parties to "transition away from fossil fuels" with the aim of limiting climate change, it was also the first COP to include a Health Day. Rising global temperatures, extreme meteorological phenomena and ecosystem change are not merely environmental concerns. They are catalysts of a silent epidemic that is affecting human health....
-
Document de presse | 2024.04.26
Bronchiolitis: two French studies demonstrate the effectiveness of Beyfortus® in preventing serious illness and reducing hospital admissions among infants
After a 2022/2023 season marked by a severe epidemic of bronchiolitis due to respiratory syncytial virus (RSV), in particular in terms of emergency department visits and hospital admissions, on September 15, 2023 the French Government launched a preventive immunization campaign, administering nirsevimab (Beyfortus®), to protect infants and reduce the circulation of the virus.To assess the...
-
News | 2022.10.05
A series of events to mark the bicentenary of Louis Pasteur’s birth
The Institut Pasteur is continuing to celebrate the bicentenary of Louis Pasteur's birth by organizing a major conference in December and also by partnering with events organized by other institutions and participating in official 2022 bicentenary festivals and conferences. Check out the calendar of events below and at www.pasteur2022.fr.
-
News | 2024.07.03
A look back at Pasteur Innov' Day 2024 : a hugely successful 2nd edition !
On June 25, 2024, the Institut Pasteur hosted the second edition of Pasteur Innov'Day. The goal was to demonstrate the potential of the Institut Pasteur's research and innovation continuum to industry players in the health sector. The event was attended by almost 150 partners (startups, SMEs, major pharmaceutical corporations, investors, and other innovation stakeholders) as well as many Institut...
-
News | 2022.12.27
Bicentenary of Louis Pasteur's birth: looking back on a year of commemorations
Two hundred years ago, on December 27, 1822, Louis Pasteur was born in the town of Dole, in the Jura region of France. The year 2022 was an opportunity to celebrate Louis Pasteur's scientific and cultural legacy and to give people a chance to discover – or rediscover – his life and work.
-
News | 2025.03.20
An international scientific alliance to strengthen the fight against infectious diseases
The Institut Pasteur and UCSF-QBI celebrated an ongoing successful scientific collaboration today, which was initiated in March 2019, and expanded significantly during the pandemic. This alliance, formalized in October 2022, aimed at bolstering the fight against infectious diseases, has already spawned more than 20 research projects, a dozen publications in high-level journals, and numerous...